Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Højgaard

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Neuro-Oncology Practice|February 7, 2025
Actionable alterations in glioblastoma: Insights from the implementation of genomic profiling as the standard of care from 2016 to 2023Vincent Fougner, Thomas Urup, Hans Skovgaard Poulsen, et al.
Frontiers in Bioengineering and Biotechnology|April 20, 2026
Histological fidelity and microenvironmental kinome signatures of metastatic patient-derived organoidsJoana Leitão-Castro, Alexia Melanie Lopresti, Kamilla Westarp Zornhagen, et al.
Cells|February 12, 2026
Immune Cell Modulation of Patient-Matched Organoid Drug Response in Precision Cancer Medicine PlatformSilje Kjølle, Mario Presti, Jéssica de Pina Roque, et al.
Journal of the National Cancer Institute|May 6, 2024
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)Elisa Fontana, Ezra Rosen, Elizabeth K Lee, et al.
BMC Cancer|February 23, 2023
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trialTina Kringelbach, Martin Højgaard, Kristoffer Rohrberg, et al.
Advanced Healthcare Materials|November 4, 2021
Modeling Metastatic Colonization in a Decellularized Organ Scaffold-Based Perfusion BioreactorMaria Rafaeva, Edward R Horton, Adina R D Jensen, et al.
Nature Medicine|June 5, 2023
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial resultsTimothy A Yap, Elisa Fontana, Elizabeth K Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2026
Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response (DDR) Aberrations: Preclinical and Phase 1b ResultsEzra Y Rosen, Timothy A Yap, Elisa Fontana, et al.
Neuro-Oncology|December 1, 2021
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumorsFrançois Doz, Cornelis M van Tilburg, Birgit Geoerger, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Neuro-Oncology Practice|February 7, 2025
Actionable alterations in glioblastoma: Insights from the implementation of genomic profiling as the standard of care from 2016 to 2023Vincent Fougner, Thomas Urup, Hans Skovgaard Poulsen, et al.
Frontiers in Bioengineering and Biotechnology|April 20, 2026
Histological fidelity and microenvironmental kinome signatures of metastatic patient-derived organoidsJoana Leitão-Castro, Alexia Melanie Lopresti, Kamilla Westarp Zornhagen, et al.
Cells|February 12, 2026
Immune Cell Modulation of Patient-Matched Organoid Drug Response in Precision Cancer Medicine PlatformSilje Kjølle, Mario Presti, Jéssica de Pina Roque, et al.
Journal of the National Cancer Institute|May 6, 2024
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)Elisa Fontana, Ezra Rosen, Elizabeth K Lee, et al.
BMC Cancer|February 23, 2023
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trialTina Kringelbach, Martin Højgaard, Kristoffer Rohrberg, et al.
Advanced Healthcare Materials|November 4, 2021
Modeling Metastatic Colonization in a Decellularized Organ Scaffold-Based Perfusion BioreactorMaria Rafaeva, Edward R Horton, Adina R D Jensen, et al.
Nature Medicine|June 5, 2023
Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial resultsTimothy A Yap, Elisa Fontana, Elizabeth K Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2026
Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response (DDR) Aberrations: Preclinical and Phase 1b ResultsEzra Y Rosen, Timothy A Yap, Elisa Fontana, et al.
Neuro-Oncology|December 1, 2021
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumorsFrançois Doz, Cornelis M van Tilburg, Birgit Geoerger, et al.
Pageof 2